Validation of previously identified serum biomarkers for breast cancer with SELDI-TOF MS: a case control study
about
Early diagnostic protein biomarkers for breast cancer: how far have we come?Clinical proteomics of breast cancerSearching for early breast cancer biomarkers by serum protein profiling of pre-diagnostic serum; a nested case-control studyIdentification of potential markers related to neoadjuvant chemotherapy sensitivity of breast cancer by SELDI-TOF MS.Proteomic studies in breast cancer (Review).Improved classification of breast cancer peptide and protein profiles by combining two serum workup proceduresProteomic serum biomarkers and their potential application in cancer screening programs.Sensitive and specific peak detection for SELDI-TOF mass spectrometry using a wavelet/neural-network based approachThe consumption of seaweed as a protective factor in the etiology of breast cancer: proof of principle.Dermcidin expression is associated with disease progression and survival among breast cancer patients.Search for breast cancer biomarkers in fractionated serum samples by protein profiling with SELDI-TOF MS.Protein biomarkers for the early detection of breast cancer.Advances in Proteomic Technologies and Its Contribution to the Field of CancerNon-invasive proteomics-thinking about personalized breast cancer screening and treatmentSerum proteomics and disease-specific biomarkers of patients with advanced gastric cancer.1H NMR Metabolomics Reveals Association of High Expression of Inositol 1, 4, 5 Trisphosphate Receptor and Metabolites in Breast Cancer PatientsFreeze-dried plasma proteins are stable at room temperature for at least 1 year.The proteins cleaved by endogenous tryptic proteases in normal EDTA plasma by C18 collection of peptides for liquid chromatography micro electrospray ionization and tandem mass spectrometry.Random and independent sampling of endogenous tryptic peptides from normal human EDTA plasma by liquid chromatography micro electrospray ionization and tandem mass spectrometry.
P2860
Q31043570-F4A98C7B-979E-4362-B68D-B3D5C44135A0Q33885885-92520CD2-450F-46B6-AAA6-918597ACBF96Q34003835-3030013D-FA95-4B13-A888-B74D173D8B19Q34086346-B16D5234-88F1-46DE-BFA5-0077771E8D52Q34319634-8AD8875A-8B48-4CCD-B136-5DECFD4D83BDQ34327104-BE5193D7-1C32-4105-A710-5068ADDC4129Q34395996-556E28B5-0BAA-43BA-835F-6E71ED6CEC2AQ34477298-DC19CE2A-81D9-416B-9E00-A310AD5CBFC8Q34725150-30E7506D-4C98-4A0B-BF18-9A5152E39FEEQ35100954-47A03CCA-89BD-49CB-B322-E53983C04D5AQ35169678-124AF2CA-61B2-46CE-881E-3623214BCB16Q35367572-8F2E68ED-0399-4153-9D90-BC0F30722A7DQ36112651-C462A1D2-B326-4F27-A688-87430725161AQ36117711-7CE7B608-3283-4EB5-8C3F-C6266E244F29Q36216932-2DA12434-1B30-451D-9C43-5D21ABCC96F9Q36245590-4E763EAF-D1F7-42FF-A796-E40DA886135DQ45887105-98EE1AAF-3C71-4917-957A-437F6BCE399BQ47158443-7F054252-312F-4041-ABD8-4F988BB718C8Q47165512-97A5C462-0A30-44FD-9635-80629311F3E4
P2860
Validation of previously identified serum biomarkers for breast cancer with SELDI-TOF MS: a case control study
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Validation of previously ident ...... I-TOF MS: a case control study
@ast
Validation of previously ident ...... I-TOF MS: a case control study
@en
type
label
Validation of previously ident ...... I-TOF MS: a case control study
@ast
Validation of previously ident ...... I-TOF MS: a case control study
@en
prefLabel
Validation of previously ident ...... I-TOF MS: a case control study
@ast
Validation of previously ident ...... I-TOF MS: a case control study
@en
P2093
P2860
P356
P1433
P1476
Validation of previously ident ...... I-TOF MS: a case control study
@en
P2093
Annemieke W J van Winden
Carla H van Gils
Emiel J Th Rutgers
Jos H Beijnen
Marie-Christine W Gast
Petra H M Peeters
P2860
P2888
P356
10.1186/1755-8794-2-4
P577
2009-01-19T00:00:00Z
P5875
P6179
1048962964